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Abstract 
In this study, 24-hour composite wastewater samples were collected from a wastewater 
treatment plant of New Zealand with parallel secondary treatment units. The aim was to 
investigate occurrence, removal, and consumption of 13 drugs of abuse (DOAs) including 
illicit drugs, alcohol, nicotine, and their metabolites. The filtered samples were analyzed 
through direct injection on LC-MS/MS. Ethyl sulfate, one of the major metabolites of alcohol, 
was detected at highest concentration (mean = 8,300 ng/L) in wastewater influent. The mean 
concentrations of methamphetamine and hydroxycotinine in the influent were found to be 935 
ng/L and 5,000 ng/L, respectively. Amphetamine (383 ng/L) and cocaine (286 ng/L) were 
detected at highest concentrations in the effluent. The removal efficiency of the treatment plant 
varied for DOAs: >99% for morphine, ethyl sulfate, and hydroxycotinine and <50% for 
methadone and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). Primary 
treatment did not show any significant removal of DOAs while the removal efficiencies of total 
monitored DOAs by Membrane Bioreactor (MBR) and Bardenpho processes were found to be 
similar (~95% removal). The population was estimated using hydrochemical parameters and 
human urine biomarkers and showed good agreement with wastewater treatment plant’s 
estimates. Weekday-weekend variation in the consumption of alcohol and methamphetamine 
was found to be significant, with a higher estimated consumption during the weekends. 
Monitored DOAs in influent were present at highest concentrations during summer (23 µg/L), 
at low concentrations during winter (17 µg/L), and at lowest concentrations during heavy 
rainfall event (11 µg/L), possibly due to dilution. The population normalised mass loads of 
DOAs were found to correlate with their metabolites, and morphine was found to correlate with 
nicotine metabolites.  
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
3 
 
Keywords: illicit drugs; wastewater; occurrence and fate; alcohol; nicotine; parallel secondary 
treatment 
 
1. Introduction 
The United Nations Office on Drugs and Crime (UNODC) has reported that an estimated 5.2% 
of the world’s population aged 15-64 used illicit drugs in 2014 (UNODC 2016).  The traditional 
self-reported survey methods do not always give an accurate estimate of illicit drug 
consumption in a community (Metcalfe et al. 2010). Wastewater based epidemiology (WBE) 
is increasingly used as a method to estimate the quantity of drug consumption in communities 
and can complement to the existing epidemiological surveys and illicit drugs seizure data 
(McCall et al. 2016, Yadav et al. 2017, Yargeau et al. 2014, Zuccato et al. 2008). Illicit drugs 
and their metabolites in wastewater influent have been reported to be in the range of <1 ng/L 
up to 10 µg/L (Yadav et al. 2017). These DOAs and their metabolites have also been detected 
in surface water ranging from sub-ng level to >100 ng/L, due to their inefficient removal during 
wastewater treatment (Yadav et al. 2017). The occurrence of these drugs, even at sub-µg/L 
concentrations in the aquatic ecosystem, may produce ecotoxicological effects (Pal et al. 2013).  
The removal efficiencies of DOAs in a wastewater treatment plant (WWTP) are still not well 
known, especially with advanced treatment processes such as membrane bioreactors (MBR) 
(Evgenidou et al. 2015, Kim et al. 2014). Although few studies have assessed removal 
efficiencies of DOAs by WWTPs (Andrés-Costa et al. 2014, Kasprzyk-Hordern et al. 2009, 
Postigo et al. 2010, Terzic et al. 2010), more research is needed to assess and compare their 
removal through conventional and advanced treatments. Furthermore, in New Zealand, the 
previous studies have mainly focussed on DOAs’ consumption, based on catchment population 
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data given by WWTP operators and wastewater influent concentrations only (Lai et al. 2017). 
There is a lack of information about occurrences of DOAs in wastewater effluents; such 
information is particularly relevant as practices of effluent application to land or its discharge 
to surface water bodies are not uncommon.  
Community drug use can be estimated by measuring the concentration of drug target residues 
(DTR) in the wastewater influent (Baker et al. 2014, Chen et al. 2014, Gatidou et al. 2016, 
Jones et al. 2014, Mastroianni et al. 2016, van Nuijs et al. 2011). Numerous WBE studies have 
been conducted across the globe, including in European Union, U.S., Australia, and Asia, as 
reported by Yadav et al. (2017) and in New Zealand (Lai et al. 2017).  The Sewage Analysis 
Core Group Europe (SCORE) also performs interlaboratory sewage analysis across Europe, 
Australia, and North America to estimate the selected drug residues in wastewater influent (van 
Nuijs et al. 2018).  
Apart from the illicit drugs, the WBE method can also estimate alcohol consumption of the 
population, served by a specific sewerage system, by quantification of the mass load of a stable 
and specific biomarker of its oxidative metabolism (Andrés-Costa et al. 2016, Boogaerts et al. 
2016, Ryu et al. 2016). Similarly, nicotine consumption in the community can also be 
monitored by near real-time sewage analysis (Castiglioni et al. 2015). WBE study not only 
reveals the consumption pattern of drugs but can also be used to estimate the de facto 
population of the catchment area served by a wastewater treatment plant by measuring the mass 
load of relatively stable biomarkers, taking into account average human excretion rate 
(Daughton 2012, O’Brien et al. 2014, Senta et al. 2015).  
Consumption of some of the drugs like methamphetamine, cocaine, and MDMA has been 
estimated using WBE in New Zealand (Lai et al. 2017); however, the consumption patterns of 
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most of the other DOAs, including alcohol and nicotine, has not been reported and hence, this 
study will also contribute to the existing community drug consumption pattern derived from 
epidemiological surveys. The social cost (includes cost of personal and community harm and 
intervention costs) associated with consumption of illicit drugs in New Zealand is estimated to 
be 1.8 billion per year(McFaddenConsultancy 2016). The estimated social cost associated with 
consumption of alcohol and nicotine is higher than illicit drugs in both Australia and New 
Zealand. Hence, it will be relevant to estimate consumption patterns of DOAs in this region 
using WBE approach.  
The principal aim of this study was to investigate the occurrence and removal of DOAs in an 
urban wastewater treatment plant in New Zealand by analysing DOAs at different stages of 
wastewater treatment in four seasons. The uniqueness of the study lies with the seasonal 
sampling at different stages of the WWTP, which had a parallel secondary treatment train, with 
conventional and advanced treatment components. Hence, the study yields comprehensive data 
on the occurrence and removal of DOAs in the studied WWTP.  Consequently, the influent and 
effluent mass loads of DOAs were used to estimate the population consumption of DOAs and 
their environmental discharges, respectively.   
2. Material and Methods 
2.1. Chemicals and consumables 
Chemicals, including isotope labelled standards, used in this study were of analytical grade and 
purchased from Cerilliant (USA). Methanol and acetonitrile (LC grade) were purchased from 
Merck (Germany). Formic acid was purchased from Sigma Aldrich (Australia).  HPLC 
columns were purchased from Phenomenex (USA). The DOAs selected for the study (Table 
S1) were methamphetamine, amphetamine, cocaine, nicotine, codeine, 3,4-methylenedioxy
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methamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-
n-ethylamphetamine (MDEA), morphine, methadone, ketamine, methylone, oxycodone, 
mephedrone, and buprenorphine, whereas metabolites included benzoylecgonine, cotinine, 
hydroxycotinine, ethyl sulfate, norketamine, and 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine (EDDP). Native and labelled analytical standards of these DOAs and their 
metabolites were obtained from various suppliers. 
Table S1 lists the 21 DOAs and DTRs, along with their physiochemical properties, chosen for 
the study.  DOAs were selected based on their global occurrence in wastewater (Pal et al. 2013) 
and compatibility with existing analytical methods.  
2.2. Sampling  
Wastewater samples were collected from an urban WWTP in New Zealand, serving a 
catchment area population of less than 100,000. This catchment area was selected for the study 
because it has been a major tourist destination in New Zealand for more than 100 years and 
was not part of the previous studies. The selected WWTP received mostly domestic wastewater 
with a minor contribution coming from industries. The main sources of trade waste were waste 
management, paints industry, dry cleaners, and meat processing plant.  The sources of 
wastewater are included in Table S2. 
The process scheme (Figure 1) included preliminary treatment (screens and grit removal), 
primary treatment (sedimentation), and secondary treatment. A secondary treatment process 
consisted of two parallel units: Bardenpho (conventional activated sludge coupled with nutrient 
removal) and Membrane Bioreactor (MBR), operating simultaneously and discharging their 
effluent to the forest for irrigation purpose. The Bardenpho system is a 5-stage biological 
treatment unit consisting of anaerobic/ anoxic/ aerobic/ anoxic/ aerobic zones, with target 
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MLSS of 4,000 mg/L, HRT of 13.5 hours, and sludge age of 12 days; whereas MBR is the 
integration of membrane filtration with biological secondary treatment, with target MLSS of 
5,000 mg/L, HRT of 19.6 hours, and sludge age of 20 days. Based on the average flow data 
supplied by the WWTP, approximately 75% of primary effluent was treated by the Bardenpho 
process and remaining by the MBR. Secondary effluents from both treatment units combine to 
yield final effluent. 
The raw and treated 24-hour composite wastewater samples of 5 litres each were collected 
daily in time proportional sampling mode, every 15 minutes over 24 hours, during a selected 
week in spring (October, 2016), summer (January, 2017), autumn (May, 2017), and winter 
(July, 2017) using ISCO autosampler (Teledyne, U.S.). Additional composite wastewater 
samples were also collected during a heavy rainfall period of consecutive four days in April 
2017 to evaluate the effects of heavy rainfall on concentrations and fate of DOAs. The sampling 
details are provided in Table S3. 
2.3 Wastewater quality characterisation 
Wastewater samples were analysed by the WWTP within 24 hours according to the Standard 
Methods (Rice et al. 2017). WWTP analysed parameters included pH, alkalinity, carbonaceous 
biochemical oxygen demand (cBOD), chemical oxygen demand (COD), dissolved reactive 
phosphorus (DRP), nitrogen (includes ammonia, nitrite, total Kjeldahl nitrogen, total oxidised 
nitrogen), total phosphorus, turbidity, and suspended solids.  
2.4 Sample processing 
All samples were acidified to pH 2 at the WWTP immediately after sampling. The samples 
were then put on ice and transferred overnight to the Environmental Engineering laboratory of 
the University of Auckland. 20 mL of collected samples were filtered with 0.2 µm PTFE 
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syringe filter to eliminate suspended particles.  pH of all the samples was verified with Thermo 
Scientific Orion 3-Star pH meter. Acidified and filtered wastewater samples were then sent to 
the University of Queensland (Australia) for analysis of the DOAs using high-performance 
liquid chromatography (Shimadzu Nexera UHPLC system, Kyoto, Japan) coupled to a triple 
quadrupole tandem mass spectrometer (AB SCIEX QTRAP®5500, Ontario, Canada).  
2.5 LC-MS/MS analysis 
Analysis was carried out using direct injection of samples on above-mentioned liquid 
chromatography tandem mass spectrometer (LC-MS/MS), thus avoiding any additional sample 
preparation and extraction steps. Samples were spiked with deuterated standards before 
analysing on LC-MS/MS for quality assurance and quality control (QA/QC) check. 
Phenomenex Biphenyl (50x2 mm, 2.6 micron) and Phenomenex Kinetek EVO C18 (50x2 mm, 
1.7 micron) LC columns were used for the separation of DOAs and ethanol metabolites, 
respectively. LC-MS/MS parameters are shown in Table S4. MS acquisition parameters for 
each DOA are detailed in Table S5. Other QA/QC measures were implemented in the similar 
way as mentioned by Lai et al. (2013b) to ensure accurate quantification of selected DOAs.  
The samples and MilliQ water laboratory blanks acidified to pH 2 (n = 3) were spiked with 
mass labelled internal standards to account for matrix effects. A six-point calibration standard 
curve was prepared in MilliQ water acidified to pH 2 and ranged in concentrations from 0.1 to 
40 μg/L.  The calibration curve (n = 6) and wastewater samples spiked with native standards 
(5 μg/L; n= 2) were analysed in duplicate and the relative differences were minimal.  The limit 
of detections (LOD) for chemicals ranged from 0.003–0.2 μg/L (Table S6). No analytes were 
detected in blank samples. The analytical method is validated yearly through an inter-
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laboratory comparison (SCORE 2015). More details of the analytical method are described in 
Text S1 and previous studies (O’Brien et al. 2014, Banks et al. 2018, Lai et al. 2017). 
2.6. Estimation of removal efficiency 
The removal efficiency was calculated based on following equation: 
Removal efficiency of treatment unit (%) = [(Average seven days influent concentration to 
WWTP - Effluent concentration for Treatment Unit)/ Average seven days influent 
concentration to WWTP *100]                       Equation (1) 
2.7 Estimation of mass loads and consumption of DOAs 
The influent mass loads for DOAs were calculated by multiplying the concentration of DOAs 
with the daily inflow to WWTP. The population normalised mass load was calculated by 
dividing the daily mass load of each DOA with daily population estimate. The consumption of 
selected pharmaceuticals (mg/d/1000 person) was estimated by multiplying the population 
normalised mass load of DOAs with respective correction factors, which take into account the 
excretion factor and the ratio of molecular weight of parent drug and DTR (Equation 2) 
(Boogaerts et al. 2016, Castiglioni et al. 2015, Lai et al. 2013a, Mastroianni et al. 2017). For 
methamphetamine, cocaine, nicotine, alcohol, and MDMA, DTRs used were 
methamphetamine, benzoylecgonine, cotinine+hydroxycotinine, ethyl sulfate, and MDMA, 
respectively. The corresponding correction factors were 2.3 (van Nuijs et al. 2011), 2.33 
(Castiglioni et al. 2015), 1.35 (Nefau et al. 2013), 3,047 (Boogaerts et al. 2016), and 1.5 
(Castiglioni et al. 2015), respectively. The correction factor of 3,047 and alcohol density of 789 
kg/m3 were used to estimate the daily consumption of pure alcohol on a volume basis 
(Rodríguez-Álvarez et al. 2015, Yin et al. 2018).  
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Estimated drug consumption = (Concentration of DOAs (mg/L)* Flow (L/d)* Correction 
factor)/Population of catchment area derived from WBE*1000    Equation (2) 
The amount of nicotine absorbed (g/day) by human body during smoking was estimated 
through the equation used by Castiglioni et al. (2015). The total nicotine absorbed was based 
on the sum of the mass loads of cotinine and hydroxycotinine, obtained by back calculation of 
their concentrations in ng/L, multiplied by correction factor of 1.35, as shown below in 
Equation 2: 
Nicotine (absorbed) = [(Concentrationcotinine*F) + (Concentrationhydroxycotinine*F)]*Correction 
factor                 Equation   (3) 
2.8. Estimation of the population served by the WWTP 
Population size was estimated using five hydrochemical parameters of wastewater: BOD, 
COD, TKN, TP, and ammonium (Chen et al. 2014, Rico et al. 2017, Senta et al. 2015). The 
population served by the WWTP was estimated by dividing the mass load of these parameters 
with their literature-reported wastewater per capita load. Mass load of BOD was divided by 60, 
COD by 128, Ammonia by 8.1, TKN by 10, and TP by 1.7 (Been et al. 2014, Rico et al. 2017).  
Population size was also estimated using human urine indicators like methadone and codeine 
as follows: 
Estimated population = (Daily mass load * Excretion factor)/Daily defined dose (DDD) per 
thousand                                 Equation (4) 
DDD per thousand of methadone and codeine were 1.91 mg and 64 mg, respectively (Ministry 
of Health 2018). The excretion factors used for codeine and methadone were 30% and 27.5% 
(Thai et al. 2016). 
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Population estimate by nicotine metabolites was calculated similarly. Nicotine is metabolised 
to cotinine, which is hydroxylated to hydroxycotinine along with other metabolites through 
enzymatic transformation (Buerge et al. 2008, Rodríguez-Álvarez et al. 2014). These 
biomarkers are excreted along with the fraction of unmetabolized nicotine in urine, after 
tobacco consumption. The number of cigarettes smoked in a day can be calculated based on 
the assumption that 1.25 mg of nicotine is absorbed while smoking one cigarette (Castiglioni 
et al. 2015). The average number of current smokers aged 15 years and more in the study area 
was reported to be 20.2% by the local district health board. Population was estimated 
considering that 76.8% of population were adults (age >15 years) in the study area, based on 
the national census of 2013. Similar approach of population estimates using nicotine was also 
done by Senta et al. (2015). 
2.9 Statistical Analysis 
The statistical analysis was carried out using IBM SPSS™ statistics 24. The Shapiro-Wilk test 
was performed to check if the sample has normal distribution of data. Parametric one way 
ANOVA followed by Tukey HSD and non-parametric Kruskal-Wallis test was performed to 
evaluate the statistical differences between different population estimates and their seasonal 
and weekday-weekend variation. Seasonal and weekday-weekend variations of DOAs 
consumption were also evaluated similarly. Non-parametric Spearman’s rank correlation 
analysis was conducted in order to correlate population normalised mass load of DOAs. 
 
3. Results and Discussion 
3.1. Occurrence and Removal of DOAs in the WWTP 
3.1.1. Concentration of DOAs in wastewater influent 
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Influent and effluent concentrations of DOAs and their comparison with international studies 
are summarised in Table 1. Out of 21, only 13 monitored DOAs were detected in the influent 
with the concentrations ranging from sub-ng/L to 15 µg/L. For calculating mean, median, and 
SD, <LOD values were excluded; however, mean and median were not calculated for 
compounds detected in only one season in the effluent. Overall, ethyl sulfate was present at 
highest concentration (mean = 8,300 ng/L), whereas MDMA (mean = 24 ng/L) was detected 
at lowest concentration among all detected DOAs. Ethyl sulfate and ethyl glucuronide are the 
two major metabolites of alcohol metabolism. Ethyl sulfate is a relatively stable and is a 
specific biomarker for alcohol consumption (Ryu et al. 2016, Wurst et al. 2006) while ethyl 
glucuronide is not stable. MDEA (<10 ng/L), ketamine (<10 ng/L), norketamine (<10 ng/L), 
methylone (<10 ng/L), mephedrone (< 30 ng/L), oxycodone (<20 ng/L), and buprenorphine 
(<50 ng/L) were not detected in any samples using the direct injection analytical protocol 
followed in this study. It was found that detection frequency was more than 90% for the 
majority of the detected DOAs, including DTRs. However, cocaine, benzoylecgonine, and 
MDMA were detected with frequency less than 15%. The mean concentrations of cotinine and 
hydroxycotinine were found to be 1,800 ng/L and 5,000 ng/L, respectively, while the mean 
concentration of nicotine was 3,000 ng/L. As can be seen from Table 1, most of the DOAs’ 
concentrations were in a similar range when compared to studies conducted elsewhere.  
The concentrations of methamphetamine, amphetamine, benzoylecgonine, ethyl sulphate, and 
MDMA were also compared with their respective concentrations in Australian wastewater 
influent. The median concentration of amphetamine and methamphetamine in this study was 
found to be significantly less than those reported by Gao et al. (2018b) in urban wastewater 
treatment plant of Australia. The WBE studies and seizure data have demonstrated that 
amphetamine consumption is prominent in Western Europe, whereas Northern Europe, 
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Slovakia, Czech Republic, and Oceania regions are dominated by methamphetamine 
consumption (Irvine et al. 2011, Ort et al. 2014). Amphetamine concentrations observed in this 
study might be due to methamphetamine metabolism in human body, causing it to appear in 
urine. However, amphetamine is also prescribed in NZ for therapeutic use. Amphetamines pills 
are sold as diet pills under the name of Duromine® and also as dexamphetamine (Dexedrine®, 
Dextrostat®) (MinistryofHealth 2010). The mean amphetamine/methamphetamine ratio was 
found to be 0.143 indicating methamphetamine consumption as a major source of amphetamine 
occurrence in these samples (Gao et al. 2018b). The mean concentration of ethyl sulphate in 
this study was found to be half of the concentration reported by Nguyen et al. (2018) in 
Australia. The mean concentration of MDMA and benzoylecgonine in this study were also 
found to be less than reported by Irvine et al. (2011) in Australian wastewater treatment plant. 
The seasonal variation in mean concentration of DOAs in influent is shown in Table 2. Most 
of the drugs did not show seasonal variations. Cocaine was detected in only summer and winter 
seasons whereas MDMA was also present in only spring and summer seasons above LOD. 
Overall, for monitored DOAs, total concentrations were found to be 30-40% higher during 
summer than winter, possibly indicating the influence of tourists and increased recreational 
activities during summer season. Temperature variations were not expected to affect the 
stability of most of the DOAs (Senta et al. 2014), and hence, those were not expected to 
contribute to seasonal variations. However, recent study (Ramin et al. 2018) indicates that 
DOAs demonstrate increasing transformation rates with increasing temperatures of 
wastewater, and thus DOAs’ influent mass loads reported in summer could be underestimated. 
Total concentrations for monitored DOAs were lowest, less than 50% of summer 
concentrations, during heavy rainfall event, which was expected due to significant dilution of 
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wastewater influent by runoff. Table S7 in the supplementary information shows the seasonal 
variation of water quality parameters in influent.   
3.1.2 Concentrations of DOAs in wastewater effluent 
Codeine was present in wastewater effluent with mean concentrations of >100 ng/L. The mean 
concentrations of cotinine and methamphetamine were found to be in range of 50-100 ng/L 
while the mean concentrations of methadone and EDDP ranged between 0-50 ng/L in the 
effluent. Amphetamine (383 ng/L), cocaine (286 ng/L), benzoylecgonine (85 ng/L), and 
MDMA (20 ng/L) were detected in only one season in the effluent. Morphine, ethyl sulfate, 
hydroxycotinine, and nicotine were not detected in any seasons in the wastewater effluent. The 
standard deviations were significantly high in effluent samples for DOAs because of seasonal 
variation in their removal.  Seasonal variations in DOAs’ mean concentrations in secondary 
effluent and final effluent are shown in Table S8 and S9, respectively. Mean removal 
efficiency of DOAs through parallel secondary treatment train of MBR and Bardenpho is 
shown in Table S10. Total population normalised effluent mass load of DOA was found to be 
218 mg/d/1,000 population. The average effluent population normalised mass load (PNML) of 
DOAs is shown in Table S11. The seasonal variation in water quality parameters in final 
effluent is shown in Table S12 while the seasonal variations in removal efficiency of water 
quality parameters is shown in Table S13. 
3.1.3 Removal efficiency of WWTP 
3.1.3.1. Primary treatment 
The average removal efficiency of primary treatment in all four seasons was found to be 
insignificant (<1%) for majority of the drugs and their metabolites. Similar insignificant 
removal of DOAs at primary treatment was also reported by Subedi and Kannan (2014) at a 
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wastewater treatment plant in the U.S.A.  The removal efficiency of primary treatment during 
a heavy rainfall period was found to be slightly better for most of the studied drugs and their 
metabolite (data not shown). One of the possible explanations is a higher amount of silt present 
during heavy rainfalls, which settles out in the primary treatment, removing with it the 
sediment-bound DOAs. Inefficiency of primary treatment indicates that sedimentation alone is 
not an efficient removal mechanism for most of the monitored DOAs. 
3.1.3.2. Secondary treatment 
MBR and Bardenpho were two parallel secondary treatment units of the studied WWTP. They 
operate simultaneously, and their effluent is mixed in an equalisation basin before discharge to 
the environment.  The average removal efficiency of hydroxycotinine, nicotine, ethyl sulfate, 
and morphine was more than 99% for both MBR and Bardenpho. Negative removal efficiency 
was observed for amphetamine at Bardenpho during summer (Tables S8). Negative removal 
efficiency can be explained by the deconjugation of glucuronides metabolites in the secondary 
treatment process (Subedi and Kannan 2014). The higher effluent concentration of 
amphetamine could be because of transformation of methamphetamine to amphetamine during 
secondary treatment (Heuett et al. 2015).   
The average methamphetamine removal was around 80% by MBR; however, complete 
removal was achieved by Bardenpho treatment.  Average removal efficiencies of cotinine by 
MBR (95%) and Bardenpho (97%) were similar. Similarly, average removal efficiencies of 
codeine by MBR and Bardenpho were 83% and 87%, respectively. Average removal efficiency 
of methadone by MBR was found to be 53%, around four times higher than Bardenpho. 
Similarly, MBR was more efficient in removing EDDP, compared to Bardenpho. This may be 
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due to higher hydrophobicity of these compounds as MBR has greater bacterial floc density, 
which can assimilate hydrophobic compounds more efficiently. 
Overall, secondary treatment was effective in removing 95% of the DOAs’ mass load. Average 
removal efficiency was more than 99% for morphine, ethyl sulfate, and hydroxycotinine, 
irrespective of seasons. Average removal of methamphetamine, codeine, and cotinine was 
found to be >80%. Average removal of methadone and EDDP ranged between 20-30%. 
Average removal of methamphetamine, cotinine, and nicotine was of same order as obtained 
by Subedi and Kannan (2014) in the U.S. study. Negative removal of amphetamine has also 
been reported by Terzic et al. (2010). Cocaine, benzoylecgonine, and MDMA removal was 
higher than the reported removal efficiencies from several studies compiled in a review article 
by Yadav et al. (2017). Average removal efficiencies of secondary treatment unit, comprising 
of both MBR and Bardenpho, are shown in Figure 2.  
The average removal efficiency of the WWTP was more than 90%, irrespective of seasons. 
This study also showed that there was insignificant difference (<5%) between removal 
efficiencies of MBR and Bardenpho for total concentration of monitored DOAs. The 
information was particularly relevant to the treatment plant as MBR installation was considered 
as an upgrade to remove trace level contaminants. Secondary treatment has been shown to be 
most effective for removal of DOAs in limited number of studies conducted on fate of illicit 
drugs in WWTP (Yadav et al. 2017). For example, differences observed in removal efficiencies 
of MDMA were solely attributed to differences in secondary treatment of studied WWTPs 
(Andrés-Costa et al. 2014). Although MBR is considered advanced wastewater treatment and 
is expected to perform better in terms of removal efficiencies for conventional parameters, 
activated sludge has also shown to be very efficient process for removal of DOAs (Yadav et 
al. 2017). Bardenpho, which is a modified form of activated sludge, has the same advantages 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
17 
 
where contaminants can get volatilised due to aeration and settled out with waste activated 
sludge, in addition to being biodegraded. These are the possible reasons for a comparable 
performance of Bardenpho to that of MBR observed in this study.  
There was insignificant variation (<5%) in Bardenpho removal of methamphetamine, 
morphine, ethyl sulfate, nicotine, cotinine, and hydroxycotinine in all seasons. Removal 
efficiency for amphetamine was found to be insignificant/negative during summer. Methadone 
removal was higher in summer and spring seasons, but substantially lower in autumn and 
winter seasons. Similarly, EDDP removal was higher in summer and autumn, compared to 
spring and winter season. Overall, summer samples did not show particularly high removal of 
total DOAs. This was contrary to most of the findings reported in the literature as the removal 
of organics during biological treatment is expected to be higher during warmer conditions.  
However, a rainfall event during our summer sampling week may have contributed to lowering 
of the temperature of wastewater and biological activity.  
There is no information about MBR removal efficiency in spring season due to sample loss in 
transportation, so Bardenpho removal in spring was treated as the average DOA removal from 
secondary treatment in spring.  Overall, there were no distinct variations (<5%) in removal of 
amphetamine, morphine, ethyl sulfate, nicotine, cotinine, cocaine, benzoylecgonine and 
hydroxy cotinine in three seasons at MBR. The removal efficiency of methadone, codeine, and 
methamphetamine was highest in autumn season (Table S10). The removal of EDDP was 
higher in winter and autumn compared to summer season. Lack of seasonal variations for 
removal of total DOAs mass load in MBR is consistent with the similar observation noted for 
Bardenpho.  
3.2. Population estimates, Mass loads, and Consumption 
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3.2.1 Estimation of population size 
Population size of the catchment was estimated using various hydrochemical parameters like 
COD, total phosphorus, cBOD, ammonium, and total nitrogen, and human urine indicators like 
methadone, codeine, cotinine, and hydroxycotinine. However, only nicotine marker was 
considered in this study for estimation of drug consumption. 
3.2.1.1 Based on hydrochemical parameters 
The mean population estimated by COD and total phosphorus were 67,845 and 62,014, 
respectively, which were in good agreement with population of 68,000 provided by wastewater 
treatment plant. The population was underestimated using cBOD (53,488) and overestimated 
using ammonium (96,325) and total nitrogen (107,381), and therefore, these parameters were 
not considered for estimating drugs’ consumption. There was no significant difference found 
between weekday and weekend population (p>0.05). There was no significant seasonal 
difference of population estimated using mass load of COD (p>0.05) either; however, 
population estimation using total phosphorus showed significant seasonal variations (Table 
S14), which could be attributed to phosphorus contribution through non-domestic sources of 
wastewater. Similarly, overestimation of population during heavy rainfall period by using COD 
is suspected because of organics washed in stormwater runoff. Hence, these hydrochemical 
parameters, although their estimates were in good agreement with WWTP estimate, were not 
used for estimation of consumption of DOAs in this study because of possible non-human 
sources of contribution to the wastewater (Senta et al. 2015).  
3.2.1.2 Based on human urine indicators 
Human urine biomarkers like cotinine, hydroxycotinine, methadone, and codeine were used to 
estimate the population per day. Average 70% of daily wastewater inflow (domestic inflow), 
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as communicated by WWTP operators (Table S2), was used to calculate population estimate. 
The population estimated by nicotine metabolites and methadone had shown good agreement 
with each other (p>0.05) as well as with the population estimated by WWTP. However, only 
nicotine metabolites were used as human urine biomarker for estimation of population. 
Methadone and codeine were not considered because of an extreme outlier in the case of 
methadone (Figure 3) and possibility of illicit use of codeine causing underestimation of 
catchment area population. There was no significant difference found between weekday and 
weekend population estimates as well as between different seasons (p>0.05). Complete 
population estimates by hydrochemical parameters and human urine indicators are shown in 
Table S14. 
3.2.2 Population normalised mass load and consumption 
The average daily PNML of DOAs in the wastewater influent is shown in Figure 4. The 
seasonal variation in influent PNML of DOAs is shown in Table S15. The PNML of cocaine 
was found to be significantly lower than Europe wide study (75.89 mg/d/1000 people-821.7 
mg/d/1000 people) of similar population range (ranging from >50,000 to <100,000) reported 
by EMCDDA (2017), except methamphetamine. The PNML of methamphetamine in this study 
was more than 20 times higher than Switzerland catchment with similar population range. 
However, the PNML of MDMA and amphetamine was found to be similar to PNMLs reported 
for catchments in France, and Switzerland and Belgium, respectively. The PNML of 
amphetamine was significantly lower than the PNML reported for a catchment in Iceland 
(169.9 mg/d/1000 person). The average number of cigarettes smoked was estimated as 
10,150±2,194 per day based on the nicotine data (Castiglioni et al. 2015). 
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 The average daily population normalised mass loads of ethyl sulfate was 1,883 mg/d/1000 
population. Therefore, the average daily alcohol consumption was found to be 7.3 L/d/1000 
person, which was significantly less than the mean alcohol consumption of 20.6 L/d/1000 
population of 20 cities, including  European, Australian and Canadian communities as studied 
by Ryu et al. (2016). The consumption of alcohol in this study was also found to be significantly 
less than national average of per capita alcohol consumption in New Zealand (~18 
mL/person/day)  (StatsNZ 2017), which could be because discrete areas may have very 
different consumption patterns, which require further investigation. A recent study by (Banks 
et al. 2018, Gao et al. 2018a) suggested that in sewer degradation of alcohol markers could be 
the reason for significant difference in per capita alcohol consumption estimated through WBE 
and epidemiological survey.  
The average daily consumption for methamphetamine and codeine was 484±73 mg/d/1000 
person and 241±26 mg/d/1000 person. The average daily consumption of methamphetamine, 
cocaine, MDMA, and alcohol was comparable to an Australian rural and urban community 
with a similar population (<150,000) (Lai et al. 2016, Yin et al. 2018). The average 
consumptions of DOAs estimated from this study were compared with wastewater influent 
studies done in New Zealand by Chappell et al. (2017) and Lai et al. (2017)  (Table 3). The 
methamphetamine and methadone consumption was found to be similar to Auckland; however, 
cocaine consumption was found to be highest compared to all the three cities. MDMA 
consumption was significantly lower than Auckland and Christchurch but higher than 
Whangarei consumption. 
The consumption of methamphetamine exhibited seasonal variation (Table S16), with highest 
consumption in a week of the winter season (p<0.05). There could many reasons for spikes in 
methamphetamine use at a site including one-off entertainment events such as rock concerts, 
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sports events, and social gatherings (motorcycle club tours), but this was not explored in the 
current study. However, consumption of alcohol, codeine, and methadone did not show any 
seasonal pattern (p>0.05). The consumption of alcohol and methamphetamine exhibited 
weekday-weekend variation in spring and winter season (Table S16), with higher consumption 
on weekends (p<0.05). The cocaine and MDMA consumption did not show significant 
weekday-weekend variation because most of the values were close to LOD. The weekday-
weekend consumption pattern was not observed for the remaining drugs in any season. 
3.2.3 Limitations of the present study 
The limitations of this study include unaccounted uncertainties due to sampling, in sewer 
stability of drug residues, and literature-reported excretion factors. Each of these uncertainties 
could cause underestimation or overestimation of per capita drug consumption. The mode of 
sampling and sampling frequency can cause error in estimation of drugs mass load and their 
consumption. Time-proportional sampling mode used in this study does not consider flow 
variations, which is less accurate than flow proportional sampling technique. Fifteen minutes 
of sampling frequency in this study could also cause uncertainty as short-term variations in 
drugs’ loads can be easily ignored (Ort et al. 2010). Data interpretation in this study was also 
based on total 31 24-hour composite influent samples and five, four, and three 24-hour 
composite effluent samples at primary, Bardenpho, and MBR effluent points, respectively. 
Furthermore, the direct injection LC-MS/MS analytical protocol followed in this study might 
have resulted in higher LOD/LOR than solid phase extraction (SPE)-LC-MS/MS. The 
discrepancy between estimation of alcohol consumption in this study estimated by WBE and 
by epidemiological surveys could be because of in-sewer degradation of alcohol markers. The 
average human excretion rates of drugs have been used in this study for back calculation, which 
also adds to the uncertainty in estimation of drug’s consumption.  
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3.2.4. Correlations  
The Spearman's correlation rank analysis was performed to understand correlations between 
PNML of various drugs, wastewater inflow, and rainfall. Our findings showed that there was 
moderate correlations among DOAs’ in influent. The correlations are marked as bold at p < 
0.05 and correlations > 0.4, as shown in Table S17. The drugs and their metabolites were found 
to correlate with each other in the wastewater influent, as expected.. The mass load of nicotine 
markers were found to correlate with morphine. This study also revealed interdependence of 
methamphetamine and methadone consumption. The interdependence of methamphetamine 
and methadone could be because of concurrent usage of opioids and methamphetamine or use 
of methadone in methadone maintenance treatment (MMT) widely used to treat addiction 
(Radfar et al. 2016, Wang et al. 2015). The interdependence of morphine, cotinine, and 
hydrocotinine may reflect the population groups overlap since smokers have more 
opportunities to use morphine in illicit or licit ways, and since morphine can result from 
transformation of 6-acetylmorphine (metabolite of heroin)  (Boleda et al. 2009). 
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4. Conclusion 
This study revealed significant presence of biomarkers of alcohol and tobacco consumption 
and methamphetamine in wastewater influent, confirming the recent findings from the United 
Nations about their prevalence in this part of the world. Primary treatment was not effective, 
which indicated that conventional WWTPs will need to rely on secondary treatments for 
removal of DOAs. Although MBR is widely acknowledged as more expensive and advanced 
treatment, it did not report higher efficiencies than Bardenpho treatment in terms of removal 
of total DOAs. Total population estimated by hydrological parameters like COD and TP and 
human urine biomarkers, methadone and nicotine, showed good agreement with each other and 
with WWTP population estimate. Daily consumption of DOAs was calculated based on daily 
population estimates calculated from nicotine metabolites. 
This study will not only aid WWTP operators but will also be of interest to environmental 
toxicologists, epidemiologists, and drug researchers. The findings confirm similar level of 
methamphetamine, cocaine, and MDMA consumption in New Zealand compared to Australia, 
and is consistent with recent seizure data and other research conducted in this part of the world. 
Although consumption patterns of DOAs were estimated in this study, due to level of 
uncertainties involved, associated with small numbers of samples and extrapolation factors 
used, more research is required before WBE could be used to evaluate public health 
interventions. 
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Figure 1. Process diagram of the WWTP 
Figure 2. Removal of selected DOAs by the secondary treatment 
Figure 3. Population estimates based on hydrochemical and human urine biomarkers 
Figure 4. Population normalised mass load (PNML) of DOAs in wastewater influent 
(mg/d/1000 person) 
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Table 1.  Influent and Effluent DOAs’ Concentrations in four seasons and Comparison 
with International Studies  
DOA  Influent (ng/L) Internati
onal 
study 
Effluent (ng/L)  Inter
natio
nal 
stud
y 
Fre
que
ncy 
of 
dete
ctio
n 
(%) 
Mini
mum 
conce
ntrati
on 
Maxi
mum 
conce
ntrati
on 
Mea
n± 
Stan
dar
d 
devi
atio
n 
Me
dia
n 
(Nu
mb
er 
of 
com
posi
te 
sam
ples 
abo
ve 
LO
D) 
 Freq
uency 
of 
detec
tion 
(%) 
Mini
mum 
conce
ntrati
on 
Maxi
mum 
conce
ntrati
on 
Me
an± 
Sta
nda
rd 
dev
iati
on 
Medi
an 
(Nu
mber 
of 
comp
osite 
samp
les 
abov
e 
LOD
) 
 
Amphe
tamine 
7 <LO
D 
1371 134
±41 
134
1 
(2 
out 
<LO
Q-
4310a
, 27-
25 <LO
D 
383 - - 
(1 out 
of 4) 
n.d.-
210 
a, 
6±2c
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of 
28) 
235b, 
43±5c
,15.8-
143d, 
9.9±7
.8e 
, 
n.d. 
d, 
1.5 
± 
1.8 e 
Metha
mpheta
mine 
100 421 1268 935
±62 
942 
(28 
out 
of 
28) 
<LO
Q-
2000 
a, 23-
225 b, 
n.d. c, 
<LO
Q-
11.7 d 
50 <LO
D 
59 58±
2 
58 
(2 out 
of 4) 
0.4-
350 
a, 
n.d. 
c, 
<LO
Q-
33.1 
d 
Cocain
e 
11 <LO
D 
167 98±
18 
98 
(3 
out 
of 
28) 
<LO
Q-
4700 
a, 
308-
2667 
b, 
115±
8 c, 
<LO
Q-
156 d, 
25 <LO
D 
286 - - 
(1 out 
of 4) 
<LO
Q-
530 
a, 
80±
8 c, 
<LO
Q-
2.14 
d, 
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56±1
9 e 
27 ± 
14 e 
Benzoy
lecgoni
ne 
11 <LO
D 
184 127
±10 
127 
(3 
out 
of 
28) 
5-
7500 
a, 
729-
3642 
b, 
241±
29 c, 
157-
3020 
d, 
186±
59 e 
25 <LO
D 
85 - - 
(1 out 
of 4) 
<LO
Q-
150
0 a, 
471
±73 
c, 
<LO
Q-
210 
d, 88 
± 83 
e 
Cotinin
e 
100 717 2615 1,80
0±2
74 
198
5 
(28 
out 
of 
28) 
145-
2680 
d 
100 41 70 54±
12 
53 
(4 out 
of 4) 
5.74
-
44.2 
d 
Hydrox
ycotini
ne 
100 2029 7966 5,00
0±5
12 
531
7 
(28 
out 
- 0 <LO
D 
<LO
D 
<L
OD 
<LO
D 
(0 out 
of 4) 
- 
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of 
28) 
Nicotin
e 
100 1082 14, 
586 
3,00
0±1
063 
261
9 
(28 
out 
of 
28) 
555-
6410 
d 
0 <LO
D 
<LO
D 
<L
OD 
<LO
D 
(0 out 
of 4) 
23.1
-
46.8 
d 
Ethyl 
sulfate 
100 4, 448 13,71  
9 
8300
±11
34 
775
1(2
8 
out 
of 
28) 
5500-
3250
0 b, 
1920
0f, 
1460-
1985
0g 
0 <LO
D 
<LO
D 
<L
OD 
<LO
D  
(0 out 
of 4) 
<LO
D g 
Morphi
ne 
100 108 334 223
±9 
228 
(28 
out 
of 
28) 
28-
1007 
a, 61-
370 b, 
30±5 
c, 
62.4–
363 d, 
294±
83 e 
0 <LO
D 
<LO
D 
<L
OD 
<LO
D 
(0 out 
of 4) 
12-
929 
a, 
48±
5 c, 
n.d.-
59 d, 
56 ± 
25 e 
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Methad
one 
100 15 80 29±
5 
26 
(28 
out 
of 
28) 
2.6-
1531 
a, 30-
383 b, 
28±0.
4 c, 
<LO
Q-
54.6 
d, 
52±1
6 e 
100 19 28 23±
4 
22 
(4 out 
of 4) 
1.4-
732 
a, 
43±
0.8 
c, 
<LO
Q-
36.8 
d, 37 
± 9 e 
EDDP 100 32 71 53±
5 
54 
(28 
out 
of 
28) 
n.d.-
1029 
a, 50-
197 b, 
75±1 
c, 
11.8-
70.2 
d, 
128±
20 e 
100 35 50 41±
7 
39 
(4 out 
of 4) 
2.6-
115
0 a, 
106
±4 c, 
16.3
-192 
d, 
123 
± 25 
e 
Codein
e 
100 317 1140 753
±49 
792 
(28 
out 
1.3-
3973 
a, 
513±
25 c, 
100 80 145 104
±28 
96 
(4 out 
of 4) 
3-
150
2 a, 
795
±32 
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of 
28) 
262±
51 e 
c, 
149 
± 31 
e 
MDM
A 
11 <LO
D 
261 24±
41 
24 
(3 
out 
of 
28) 1 
<0.5-
598 a, 
23-
287 b, 
131±
2 c, 
1.09-
62.5 
d, 
6.8±7
.7 e 
251 <LO
D 
201 - - 
(1 out 
of 4) 
<LO
D-
376 
a, 
67±
5 c, 
<LO
Q-
62.3 
d, 
2.4 
± 
1.7 e 
a (Yadav et al. 2017); b (Mastroianni et al. 2017); c (Yargeau et al. 2014); d (Subedi and Kannan 2014); e (Terzic 
et al. 2010); f (Mastroianni et al. 2014); g (Andrés-Costa et al. 2016);  1A concentration above the LOD but below 
LOR, is included if it is greater than the midpoint between the LOD and LOR (i.e. (LOD + LOR)/2) 
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Table 2. Seasonal Variation of DOAs in Influent (Mean ± Standard Deviation) 
Influent DOA Spring (ng/L) Summer 
(ng/L) 
Autumn 
(ng/L) 
Winter 
(ng/L) 
Heavy 
rainfall  
(ng/L) 
Amphetamine <LOD <LOD 134± 41 <LOD 1871 
Methamphetamine 943±251 932±288 1,008±203 857±238 542±132 
Cocaine <LOD 110±81 <LOD 85 183 
Benzoylecgonine <LOD 135±70 <LOD 120 1,780 
Cotinine 1,933±417 2,126±521 1,841±221 1,472±458 962±351 
Hydroxycotinine 5,117± 1,048 5,614± 1,781 5,110± 649 4,371± 1,522 2,590± 815 
Nicotine 2,863±654 4,509±4,515 2,315±357 2,208±676 1,145±497 
Ethyl sulfate 8,183±2,297 8,799±2,228 9,333±3,794 6,707±1,763 3,431±1,322 
Morphine 227±55 233±58 216±40 215±86 101±79 
Methadone 28±7 29±7 35±20 23±3 17±6 
EDDP 59± 13 52± 12 51± 6 48± 8 40± 6 
Codeine 798±176 774±197 757±136 684±266 383±136 
MDMA 211 261 <LOD <LOD <LOD 
Total 20,172 23,339 20,800 16,790 11,361 
1A concentration above the LOD but below LOR, is included if it is greater than the midpoint between the LOD 
and LOR (i.e. (LOD + LOR)/2) 
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Table 3. Comparison of DOAs consumption with previously published data for New 
Zealand (all values in mg/d/1000 person) 
DOA Present study 
(population 
~70,000) 
Christchurch 
(population  
~375,000) 
Auckland 
(population  
~1,600,000) 
Whangarei 
(population  
~77,000) 
Methamphetamine 484±73 240± 431 411±501, 
360±1122 
900± 1671 
Cocaine 94±34 15± 21 57±41, 
30.3±5.62 
4± 31 
MDMA 16±1 161± 551 94±481, 
60.2± 13.12 
7± 61 
Codeine 241±26 No data 
available 
499±1702 No data 
available 
Methadone 44±9 No data 
available 
38 ±12.72 No data 
available 
  1(Chappell et al. 2017); 2 (Lai et al. 2017) 
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Highlights: 
 First comprehensive study in WWTP of New Zealand to delineate fate of illicit drugs 
 Primary treatment was ineffective; MBR and Bardenpho showed ~95% removal of DOAs 
 Biomarkers of alcohol, tobacco, and methamphetamine dominant in wastewater influent  
 Amphetamine and cocaine detected at highest concentrations in wastewater effluent 
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